NEW YORK/BOSTON, Feb 23 (Reuters) - Swiss drugmaker Roche Holding AG (ROG.VX: Quote, Profile, Research) said on Friday it had suspended enrollment in a trial of an experimental anemia drug due to safety concerns, a setback analysts said could delay the drug’s U.S. approval.
